Treatment with CFTR modulators was safe during pregnancy and breastfeeding in two women with cystic fibrosis (CF), according…
Articles by Patricia Inácio, PhD
The levels of fecal calprotectin protein increase during pulmonary exacerbations — times when respiratory symptoms suddenly worsen — then…
SpliSense has launched a Phase 1/2 clinical trial to test SPL84, its inhaled treatment candidate for cystic…
The Cystic Fibrosis Foundation has invested another $4.85 million — termed an equity investment — in Aridis Pharmaceuticals…
Vertex Pharmaceuticals is launching a clinical trial to test VX-522, its inhaled messenger RNA (mRNA) therapy for lung disease…
Twice-weekly sessions of airway clearance physiotherapy over eight weeks led to clinically meaningful reductions in respiratory symptoms in people with…
Prolonged use of certain medications used to treat acid reflux, called proton pump inhibitors (PPIs), may put people with cystic…
Carmine Therapeutics has completed series A financing to support the development of its innovative, non-viral gene therapy for…
First Wave BioPharma has developed a new optimized formulation of adrulipase, a yeast-derived enzyme designed to treat exocrine pancreatic insufficiency…
A compound called beta-sitosterol, abundant in plants, eased the burden of Pseudomonas aeruginosa infection — a common bacteria infecting the…